[ Price : $8.95]
FDA grants Johnson & Johnson a fast track designation for its investigational therapy, nipocalimab and its use for treating adult ...[ Price : $8.95]
Medtronic Neurovascular recalls its Compatible Pipeline Vantage Embolization (027) Devices and updating the use instructions for t...[ Price : $8.95]
FDA rehires over 1,000 probationary employees that were fired last month after a Maryland federal judge ordered HHS and other fede...[ Price : $8.95]
Incyte says it will file an NDA for its JAK1 inhibitor povorcitinib and its use in adult patients with moderate to severe hidraden...[ Price : $8.95]
Three former executives of Magellan Diagnostics plead guilty to federal charges after concealing a medical device malfunction invo...[ Price : $8.95]
Orca Bio says its pivotal Phase 3 Precision-T study of Orca-T, an allogeneic T-cell immunotherapy, in certain leukemia patients me...[ Price : $8.95]
FDA lifts a clinical hold against vTv Therapeutics cadisegliatin clinical program evaluating the first-in-class oral adjunctive th...[ Price : $8.95]
AstraZeneca reports positive data from the CALYPSO Phase 3 hypoparathyroidism trial, showing eneboparatide met its primary endpoin...